Adolescent Vaccination in Pharmacies
NCT01960088 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1509
Last updated 2018-04-24
Summary
The study aims to expand the evidence supporting pharmacy provision of adolescent vaccines, including human papillomavirus (HPV) vaccine. In the first part of the study, we will characterize parents' attitudes and support for pharmacy provision of adolescent vaccines in a national survey. In the second part of the study, we will provide HPV vaccines and other vaccines (Tdap, meningococcal, varicella, influenza) to 200 adolescents in a local community pharmacy in Chapel Hill, North Carolina. This portion of the study will identify the systems and workflow needed to provide vaccines effectively and safely, characterize parents' and their adolescents' attitudes toward receiving vaccine services in a pharmacy, and characterize pharmacists' attitudes toward providing adolescent vaccine services in a pharmacy.
Conditions
- Evaluating Attitudes Toward HPV Vaccinations in Pharmacies
- Evaluating the Provision of HPV Vaccines in a Pharmacy
Interventions
- DRUG
-
HPV vaccine
Sponsors & Collaborators
- collaborator INDUSTRY
-
University of North Carolina, Chapel Hill
lead OTHER
Principal Investigators
-
Noel T Brewer, PhD · University of North Carolina, Chapel Hill
Eligibility
- Min Age
- 11 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-07-31
- Primary Completion
- 2018-04-30
- Completion
- 2018-04-30
Countries
- United States
Study Locations
More Related Trials
-
Alternate Dosing Schedules Study for HPV Vaccine
NCT00862810 ·Status: COMPLETED ·Phase: PHASE4
-
SDH of HPV Vaccine Completion
NCT03709602 ·Status: COMPLETED
-
Increasing Optimal Use of HPV Vaccination in Primary Care
NCT04180462 ·Status: COMPLETED ·Phase: NA
-
A Phase III Study of a 2-dose Regimen of a Multivalent Human Papillomavirus (HPV) Vaccine (V503), Administered to 9 to 14 Year-olds and Compared to Young Women, 16 to 26 Years Old (V503-010)
NCT01984697 ·Status: COMPLETED ·Phase: PHASE3
-
Antibody Response to Prophylactic QHPV Vaccine at 48 Months Among HIV-infected Girls and Boys
NCT04711265 ·Status: COMPLETED
-
The STOP-HPV Trial 1: Communication Intervention
NCT03599557 ·Status: COMPLETED ·Phase: NA
-
The STOP-HPV Trial 5: Single Arm Evaluation of the Bundle
NCT03609320 ·Status: UNKNOWN ·Phase: NA
-
A Phase I Trial Evaluate the Safety and Tolerability Profile of HPV Vaccine
NCT05680454 ·Status: COMPLETED ·Phase: PHASE1
-
IMPAACT P1085: Human Papilloma Virus (HPV) Type-Specific Antibody
NCT01206556 ·Status: COMPLETED
-
Improving HPV Vaccination Rates Among Rural and Native American Adolescents
NCT03801603 ·Status: COMPLETED ·Phase: NA
-
Alternate Dosing Schedules Study for HPV Vaccine (ADS)
NCT02280642 ·Status: COMPLETED
-
Quality Improvement Strategies to Increase Human Papillomavirus (HPV) Vaccination
NCT03442062 ·Status: COMPLETED ·Phase: NA
-
A Study to Compare the Impact of a School Based HPV Program on Vaccination Uptake and Completion Rates
NCT01526551 ·Status: COMPLETED ·Phase: NA
-
Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls
NCT03206255 ·Status: COMPLETED
-
Evaluation of Long-term HPV Vaccine Efficacy
NCT01393470 ·Status: UNKNOWN
-
The STOP-HPV Trial 3: Prompts Intervention
NCT03599583 ·Status: UNKNOWN ·Phase: NA
-
The STOP-HPV Trial 4: Bundle Intervention
NCT03609242 ·Status: UNKNOWN ·Phase: NA
-
Effectiveness and B-memory Cell Response to QHPV Vaccine 9-years Post-vaccination Among HIV-infected Boys and Girls
NCT04920526 ·Status: UNKNOWN
-
Human Papilloma Virus Vaccine Safety and Immunogenicity Trial in Young Adolescent Women With GSK Bio HPV-16/18.
NCT00196924 ·Status: COMPLETED ·Phase: PHASE3
-
Video to Promote HPV Vaccination
NCT02196454 ·Status: COMPLETED ·Phase: NA
-
A Phase III Study of Human Papillomavirus (HPV)-16/18 Vaccine.
NCT02733068 ·Status: COMPLETED ·Phase: PHASE3
-
Human Papilloma Virus Vaccine Consistency and Non-inferiority Trial in Young Adult Women With GSK Bio HPV-16/18
NCT00169494 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness of the Q-HPV Vaccine 9-years Post Vaccination Among HIV Positive Adolescents
NCT05435209 ·Status: COMPLETED ·Phase: PHASE4
-
HPV Vaccination Health-promotion Programme on Vaccine Acceptance and Uptake Among Female Adolescents
NCT04438291 ·Status: COMPLETED ·Phase: NA
-
Randomized Trial of Alternative HPV Vaccination Schedules in Males in a University Setting
NCT01184079 ·Status: COMPLETED ·Phase: NA